This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Obesity Science & Innovation
September 16-17, 2025
Hynes Convention CenterBoston, US
Book Now
Menu
Book

Dan Swisher
CEO at Nodthera
Speaker

Agenda Sessions

  • Utilising Small Molecule NLRP3 Inflammasome Inhibitors to Treat Inflamed Obese Patients

    , 09:25
    View Session

At this event

Prev
Next
Camille Bedrosian
CMO
Amylyx Pharma

See Dan at Obesity Science & Innovation

Book Now